Lok Sabha approves bill to expand J&K pharmacists’ job opportunities

NEW DELHILok Sabha on Monday passed a bill allowing those qualified or registered under the Jammu & Kashmir Pharmacy Act to be registered as pharmacists under the Pharmacy Act, thus doing away with the ambiguity with regard to the two legislations.

Piloting the Pharmacy (Amendment) Bill, 2023, health minister Mansukh Mandaviya said changes will increase job opportunities for the youth of J&K.
The bill, which was passed by voice vote in the Lower House, seeks to do away with issues concerning the status of persons registered or qualified under the Jammu & Kashmir Pharmacy Act. Under the current dispensation, registration under the Pharmacy Act is mandatory for people practising pharmacy in the country.

He also said the situation in Jammu & Kashmir has changed significantly after abrogation of Article 370.

Related Posts

KGMU prof suspended for forcing patients to buy meds from pvt store

Lucknow: Faculty member in the ophthalmology department of KGMU, Prof Sanjiv Gupta, was suspended on charges of prescribing medicines and lenses for cataract surgery that were available at a private…

CDSCO receives 1,387 adverse drug reaction reports in nine months of 2025

New Delhi: The pharmacovigilance division of the Central drug regulator has received a total of 1,387 adverse reports, with the highest regarding fixed dose combinations (FDCs), and a total of…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

KGMU prof suspended for forcing patients to buy meds from pvt store

KGMU prof suspended for forcing patients to buy meds from pvt store

World Record in Robotic Tele-Surgery takes Intercontinental Leap of 20,000 Km

World Record in Robotic Tele-Surgery takes Intercontinental Leap of 20,000 Km

CDSCO receives 1,387 adverse drug reaction reports in nine months of 2025

CDSCO receives 1,387 adverse drug reaction reports in nine months of 2025

NGT issues notice to Himachal pharma unit over pollution, water diversion allegations

NGT issues notice to Himachal pharma unit over pollution, water diversion allegations

Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concerns

Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concerns

DGFT Fixes Six New Standard Input Output Norms (SIONs) for Pharmaceutical and Chemical Exports

DGFT Fixes Six New Standard Input Output Norms (SIONs) for Pharmaceutical and Chemical Exports